Aliqopa drug (copanlisib) is for the treatment of adults with relapsed follicular lymphoma who have received systemic therapies. For patients with relapsed follicular lymphoma, the cancer often comes after multiple treatments.
Follicular lymphoma is a slow-growing type of non-Hodgkin lymphoma, a cancer of the lymph system. The lymph system is part of the body’s immune system and is made up of lymph tissue, lymph nodes, the spleen, thymus, tonsils and bone marrow.
Aliqopa is a kinase inhibitor that works by blocking several enzymes that promote cell growth. Common side effects of Aliqopa include high blood sugar levels, diarrhea, fatigue, high blood pressure, low levels of certain white blood cells, nausea, lower respiratory tract infections, and low levels of blood platelets.
Serious side effects include infections, high blood sugar levels, hypertension, inflammation of the lung tissues, low neutropenia and severe skin reactions. Women who are pregnant or breastfeeding should not take Aliqopa because it may cause harm to a developing fetus or newborn baby.
haleplushearty.blogspot.com
No comments:
Post a Comment